Review of the 2nd day of the II Scientific and Practical Conference in a hybrid format “Achievements, problems and prospects in hematology”. Treatment and diagnosis of patients wit... Dahkki V. A. Shuvaev

Viečča ollesdeavstta

How we treat polycythemia vera Dahkki V. A. Shuvaev, I. S. Martynkevich

Viečča ollesdeavstta

All we know about polycythemia vera: literature review and own experience Dahkki K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Viečča ollesdeavstta

Dasatinib: ten years of clinical practice worldwide Dahkki K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Viečča ollesdeavstta

Primary myelofibrosis: own experience and news from diagnostic and treatment Dahkki K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Viečča ollesdeavstta

Primary myelofibrosis: own experience and news from diagnostic and treatment Dahkki K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Viečča ollesdeavstta

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission Dahkki V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Viečča ollesdeavstta

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission Dahkki V. A. Shuvaev, K. M. Abdulkadyrov, I. S. Martynkevich, M. S. Fominykh

Viečča ollesdeavstta

Pharmacoeconomic analysis of thrombopoietin receptor agonists in the treatment of chronic idiopathic thrombocytopenic purpura in adults Dahkki E. A. Pyadushkina, M. Yu. Frolov, V. A. Shuvaev, V. A. Rogov

Viečča ollesdeavstta

Clinical Case of Posterior Reversible Encephalopathy Syndrome in a Female Patient Undergoing Surgery for Rectal Cancer Dahkki M. M. Geraskinа, A. B. Galitsynа, V. A. Shuvaev, S. S. Gosteva

Viečča ollesdeavstta

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma Dahkki S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Viečča ollesdeavstta

Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma Dahkki S. V. Voloshin, Yu. A. Krivolapov, A. V. Shmidt, V. A. Shuvaev, M. S. Fominykh, K. M. Abdulkadyrov

Viečča ollesdeavstta

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis Dahkki M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Viečča ollesdeavstta

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients Dahkki V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Viečča ollesdeavstta

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients Dahkki V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Viečča ollesdeavstta

Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia Dahkki D. V. Kustova, E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova, E. V. Morozova, E. G. Lomaia, V. A. Shuvaev, S. V. Sidorkevich, I. S. Martynkevich

Viečča ollesdeavstta

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA Dahkki A. A. Zhernyakova, I. S. Martynkevich, V. A. Shuvaev, L. B. Polushkina, M. S. Fominykh, V. Yu. Udal’eva, I. I. Zotova, D. I. Shiсhbabaeva, S. V. Voloshin, S. S. Бессмельцев, A. V. Chechetkin, K. M. Abdulkadyrov

Viečča ollesdeavstta

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients Dahkki S. V. Voloshin, A. D. Garifullin, A. A. Kuzyaeva, N. N. Sinitsina, N. N. Alekseeva, A. V. Schmidt, S. Y. Linnikov, V. A. Shuvaev, A. Y. Kuvshinov, N. A. Potikhonova, A. V. Seltser, V. A. Balashova, Z. V. Chubukina, A. N. Bogdanov, S. V. Sidorkevich

Viečča ollesdeavstta

Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy Dahkki A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko

Viečča ollesdeavstta